Many women throughout the world have history of subfertility (resolved or unresolved), but much remains unknown about services and treatments chosen.
Methods
We developed a mixed-mode fertility experiences questionnaire (FEQ) in 2009 through literature review and iterative pilot work to optimize question format and mode of administration. The focus of the FEQ is to collect data retrospectively on time at risk for pregnancy, fertility treatments received and declined, pregnancy, time to pregnancy and pregnancy outcomes. We conducted a validation of key elements of the FEQ with comparison to medical records in 2009 and 2010. The validation sample was selected from women initially seen at a specialized fertility treatment center in Utah in 2004.
Results
The FEQ was optimized with two components: 1) written (paper or web-based), self-administered, followed by 2) telephoneadministered questions. In 63 patients analyzed, high levels of correlation were identified between patient self-report and medical records for the use of intrauterine insemination and assisted reproductive technology, pregnancy and live birth histories, time at risk for pregnancy and time to pregnancy. There was low correlation between medical records and self-report for the use of oral ovulation drugs and injectable ovulation drugs. Compared to the medical record, the FEQ was over 90% sensitive for all elements, except injectable ovulation drugs (70% sensitivity).
Conclusions
The FEQ accurately captured elements of fertility treatment history at 5-6 years after the first visit to a specialty clinic.
fertility experiences questionnaire development, subfertility questionnaire validation, time to pregnancy self-report measure, fertility treatment survey instrument, FEQ questionnaire pilot validation, infertility treatment utilization survey, reproductive history questionnaire design, subfertility research instrument, fertility treatment assessment tool, mixed-mode fertility survey validation
PMID 26184507 26184507 DOI 10.1186/s12978-015-0054-3 10.1186/s12978-015-0054-3
Cite this article
Thomas, F. S., Stanford, J. B., Sanders, J. N., Gurtcheff, S. E., Gibson, M., Porucznik, C. A., & Simonsen, S. E. (2015). Development and initial validation of a fertility experiences questionnaire. *Reproductive health*, *12*, 62. https://doi.org/10.1186/s12978-015-0054-3
Thomas FS, Stanford JB, Sanders JN, Gurtcheff SE, Gibson M, Porucznik CA, et al. Development and initial validation of a fertility experiences questionnaire. Reprod Health. 2015;12:62. doi:10.1186/s12978-015-0054-3
Thomas, F. S., et al. "Development and initial validation of a fertility experiences questionnaire." *Reproductive health*, vol. 12, 2015, pp. 62.
IMPORTANCE: Because analytic technologies improve, increasing amounts of data on methylation differences between assisted reproductive technology (ART) and unassisted conceptions are available. Howeve...
The number of sperm that reaches the oocytes in mammalian species is limited. In mice, 8-10 oocytes are ovulated, a similar number of sperm reaches the oocytes, and nearly all oocytes are fertilized v...
Sanders JN et al., 2016Paediatric and Perinatal Epidemiology
BACKGROUND: Most cohort-based research for subfertility has been conducted in clinic-based cohorts, which may differ from population-based cohorts.
METHODS: We retrospectively recruited parallel coho...
Schisterman EF et al., 2013Paediatric and perinatal epidemiology
Background: Low-dose aspirin (LDA) has been proposed to improve pregnancy outcomes in couples experiencing recurrent pregnancy loss. However, results from studies of LDA on pregnancy outcomes have bee...